Interestingly, we observed that treatment with systemic corticosteroids was associated with lower periostin levels, while those on montelukast had higher IL-6 in plasma, independently from the asthma severity and other potential confounders, including age, BMI, or co-morbidities. Here, IL6 is linked to asthma.